Trial Profile
Clinical trial of ITI 007 in patients with bipolar disorders
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Apr 2014
Price :
$35
*
At a glance
- Drugs Lumateperone (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- Sponsors Intra-Cellular Therapies
- 25 Mar 2014 New trial record